ABX-EGF: Began Phase I trial

Abgenix Inc. (ABGX), Fremont, Calif. Product: ABX-EGF Business: Cancer Therapeutic category: Antibody, Receptor antagonist Target: Human epidermal growth factor (EGFr) receptor Description: Human mon...